Literature DB >> 20398908

Comprehensive copy number variant (CNV) analysis of neuronal pathways genes in psychiatric disorders identifies rare variants within patients.

Ester Saus1, Anna Brunet, Lluís Armengol, Pino Alonso, José M Crespo, Fernando Fernández-Aranda, Miriam Guitart, Rocío Martín-Santos, José Manuel Menchón, Ricard Navinés, Virginia Soria, Marta Torrens, Mikel Urretavizcaya, Vicenç Vallès, Mònica Gratacòs, Xavier Estivill.   

Abstract

BACKGROUND: Copy number variations (CNV) have become an important source of human genome variability noteworthy to consider when studying genetic susceptibility to complex diseases. As recent studies have found evidences for the potential involvement of CNVs in psychiatric disorders, we have studied the dosage effect of structural genome variants as a possible susceptibility factor for different psychiatric disorders in a candidate gene approach.
METHODS: After selection of 68 psychiatric disorders' candidate genes overlapping with CNVs, MLPA assays were designed to determine changes in copy number of these genes. The studied sample consisted of 724 patients with psychiatric disorders (accounting for anxiety disorders, mood disorders, eating disorders and schizophrenia) and 341 control individuals.
RESULTS: CNVs were detected in 30 out of the 68 genes screened, indicating that a considerable proportion of neuronal pathways genes contain CNVs. When testing the overall burden of rare structural genomic variants in the different psychiatric disorders compared to control individuals, there was no statistically significant difference in the total amount of gains and losses. However, 14 out of the 30 changes were only found in psychiatric disorder patients but not in control individuals. These genes include GRM7, previously associated to major depression disorder and bipolar disorder, SLC6A13, in anxiety disorders, and S100B, SSTR5 and COMT in schizophrenia.
CONCLUSIONS: Although we have not been able to found a clear association between the studied CNVs and psychiatric disorders, the rare variants found only within the patients could account for a step further towards understanding the pathophysiology of psychiatric disorders.
Copyright © 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20398908     DOI: 10.1016/j.jpsychires.2010.03.007

Source DB:  PubMed          Journal:  J Psychiatr Res        ISSN: 0022-3956            Impact factor:   4.791


  33 in total

1.  MACROD2 gene associated with autistic-like traits in a general population sample.

Authors:  Rachel M Jones; Gemma Cadby; John Blangero; Lawrence J Abraham; Andrew J O Whitehouse; Eric K Moses
Journal:  Psychiatr Genet       Date:  2014-12       Impact factor: 2.458

Review 2.  Evidence demonstrating role of microRNAs in the etiopathology of major depression.

Authors:  Yogesh Dwivedi
Journal:  J Chem Neuroanat       Date:  2011-04-14       Impact factor: 3.052

3.  12p13.33 microdeletion including ELKS/ERC1, a new locus associated with childhood apraxia of speech.

Authors:  Julien Thevenon; Patrick Callier; Joris Andrieux; Bruno Delobel; Albert David; Sylvie Sukno; Delphine Minot; Laure Mosca Anne; Nathalie Marle; Damien Sanlaville; Marlène Bonnet; Alice Masurel-Paulet; Fabienne Levy; Lorraine Gaunt; Sandra Farrell; Cédric Le Caignec; Annick Toutain; Virginie Carmignac; Francine Mugneret; Jill Clayton-Smith; Christel Thauvin-Robinet; Laurence Faivre
Journal:  Eur J Hum Genet       Date:  2012-06-20       Impact factor: 4.246

Review 4.  Practical Strategies and Concepts in GPCR Allosteric Modulator Discovery: Recent Advances with Metabotropic Glutamate Receptors.

Authors:  Craig W Lindsley; Kyle A Emmitte; Corey R Hopkins; Thomas M Bridges; Karen J Gregory; Colleen M Niswender; P Jeffrey Conn
Journal:  Chem Rev       Date:  2016-02-16       Impact factor: 60.622

Review 5.  Zebrafish models in neuropsychopharmacology and CNS drug discovery.

Authors:  Kanza M Khan; Adam D Collier; Darya A Meshalkina; Elana V Kysil; Sergey L Khatsko; Tatyana Kolesnikova; Yury Yu Morzherin; Jason E Warnick; Allan V Kalueff; David J Echevarria
Journal:  Br J Pharmacol       Date:  2017-04-05       Impact factor: 8.739

6.  Genome-wide association study of personality traits in bipolar patients.

Authors:  Ney Alliey-Rodriguez; Dandan Zhang; Judith A Badner; Benjamin B Lahey; Xiaotong Zhang; Stephen Dinwiddie; Benjamin Romanos; Natalie Plenys; Chunyu Liu; Elliot S Gershon
Journal:  Psychiatr Genet       Date:  2011-08       Impact factor: 2.458

Review 7.  Genetics of GABAergic signaling in nicotine and alcohol dependence.

Authors:  Wen-Yan Cui; Chamindi Seneviratne; Jun Gu; Ming D Li
Journal:  Hum Genet       Date:  2011-11-03       Impact factor: 4.132

8.  microRNAs as Biomarker in Depression Pathogenesis.

Authors:  Yogesh Dwivedi
Journal:  Ann Psychiatry Ment Health       Date:  2013-12-02

Review 9.  The involvement of microRNAs in major depression, suicidal behavior, and related disorders: a focus on miR-185 and miR-491-3p.

Authors:  Gianluca Serafini; Maurizio Pompili; Katelin F Hansen; Karl Obrietan; Yogesh Dwivedi; Noam Shomron; Paolo Girardi
Journal:  Cell Mol Neurobiol       Date:  2013-11-09       Impact factor: 5.046

Review 10.  Evolution of genetic and genomic features unique to the human lineage.

Authors:  Majesta O'Bleness; Veronica B Searles; Ajit Varki; Pascal Gagneux; James M Sikela
Journal:  Nat Rev Genet       Date:  2012-12       Impact factor: 53.242

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.